Oxford Biomedica plc (FRA:OXOA)

Oxford Biomedica Statistics

Total Valuation

FRA:OXOA has a market cap or net worth of EUR 847.10 million. The enterprise value is 905.73 million.

Market Cap	847.10M
Enterprise Value	905.73M

Important Dates

The next estimated earnings date is Wednesday, December 24, 2025.

Earnings Date	Dec 24, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	120.50M
Shares Outstanding	n/a
Shares Change (YoY)	+2.96%
Shares Change (QoQ)	+4.23%
Owned by Insiders (%)	0.42%
Owned by Institutions (%)	47.03%
Float	62.96M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.80
PB Ratio	22.19
P/TBV Ratio	86.33
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-20.95
EV / Sales	5.27
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-64.54

Financial Position

The company has a current ratio of 1.89, with a Debt / Equity ratio of 3.22.

Current Ratio	1.89
Quick Ratio	1.59
Debt / Equity	3.22
Debt / EBITDA	n/a
Debt / FCF	-8.76
Interest Coverage	-2.28

Financial Efficiency

Return on equity (ROE) is -75.20% and return on invested capital (ROIC) is -10.73%.

Return on Equity (ROE)	-75.20%
Return on Assets (ROA)	-7.44%
Return on Invested Capital (ROIC)	-10.73%
Return on Capital Employed (ROCE)	-18.72%
Revenue Per Employee	196,007
Profits Per Employee	-48,044
Employee Count	850
Asset Turnover	0.66
Inventory Turnover	5.25

Taxes

In the past 12 months, FRA:OXOA has paid 1.78 million in taxes.

Income Tax	1.78M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +42.14% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+42.14%
50-Day Moving Average	6.90
200-Day Moving Average	4.87
Relative Strength Index (RSI)	54.50
Average Volume (20 Days)	13

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:OXOA had revenue of EUR 176.41 million and -43.24 million in losses. Loss per share was -0.42.

Revenue	176.41M
Gross Profit	77.84M
Operating Income	-32.01M
Pretax Income	-43.82M
Net Income	-43.24M
EBITDA	-14.66M
EBIT	-32.01M
Loss Per Share	-0.42

Balance Sheet

The company has 62.85 million in cash and 122.99 million in debt, giving a net cash position of -60.13 million.

Cash & Cash Equivalents	62.85M
Total Debt	122.99M
Net Cash	-60.13M
Net Cash Per Share	n/a
Equity (Book Value)	38.18M
Book Value Per Share	0.36
Working Capital	72.41M

Cash Flow

In the last 12 months, operating cash flow was -9.14 million and capital expenditures -4.89 million, giving a free cash flow of -14.03 million.

Operating Cash Flow	-9.14M
Capital Expenditures	-4.89M
Free Cash Flow	-14.03M
FCF Per Share	n/a

Margins

Gross margin is 44.12%, with operating and profit margins of -18.15% and -24.51%.

Gross Margin	44.12%
Operating Margin	-18.15%
Pretax Margin	-24.84%
Profit Margin	-24.51%
EBITDA Margin	-8.31%
EBIT Margin	-18.15%
FCF Margin	n/a

Dividends & Yields

FRA:OXOA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.96%
Shareholder Yield	-2.96%
Earnings Yield	-5.10%
FCF Yield	-1.66%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on May 30, 2018. It was a reverse split with a ratio of 0.02.

Last Split Date	May 30, 2018
Split Type	Reverse
Split Ratio	0.02

Scores

FRA:OXOA has an Altman Z-Score of -0.87 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.87
Piotroski F-Score	4